BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8919826)

  • 1. Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus.
    Weber B; Brunner M; Preiser W; Doerr HW
    J Virol Methods; 1996 Mar; 57(1):87-93. PubMed ID: 8919826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparison of the detection of IgM antibodies against the viral capsid antigen (VCA) of EBV (Epstein-Barr virus) in various groups of patients, using indirect immunofluorescence, indirect ELISA and reverse ELISA. Study of the diagnostic efficacy of the anti-VCA EBV IgM ELISA-VIDITEST kit].
    Pumannová M; Rezbová M; Svecová M; Hrbácková H; Novotná M; Ochotná J; Roubalová K
    Klin Mikrobiol Infekc Lek; 2004 Aug; 10(4):186-90. PubMed ID: 15328576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Abbott Architect, Siemens Immulite, bioMerieux Vidas, and Euroimmune assays for determination of Epstein-Barr virus serological diagnosis.
    Appak O; Ozkaratas MH; Sayiner AA
    J Med Virol; 2021 Nov; 93(11):6309-6316. PubMed ID: 34375007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of four commercially available Epstein-Barr virus enzyme immunoassays with an immunofluorescence assay as the reference method.
    Gärtner BC; Hess RD; Bandt D; Kruse A; Rethwilm A; Roemer K; Mueller-Lantzsch N
    Clin Diagn Lab Immunol; 2003 Jan; 10(1):78-82. PubMed ID: 12522043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Architect Epstein-Barr Virus (EBV) viral capsid antigen (VCA) IgG, VCA IgM, and EBV nuclear antigen 1 IgG chemiluminescent immunoassays for detection of EBV antibodies and categorization of EBV infection status using immunofluorescence assays as the reference method.
    Corrales I; Giménez E; Navarro D
    Clin Vaccine Immunol; 2014 May; 21(5):684-8. PubMed ID: 24623623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological diagnosis of Epstein-Barr virus infection by novel ELISAs based on recombinant capsid antigens p23 and p18.
    Färber I; Hinderer W; Rothe M; Lang D; Sonneborn HH; Wutzler P
    J Med Virol; 2001 Apr; 63(4):271-6. PubMed ID: 11241457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies.
    Bruu AL; Hjetland R; Holter E; Mortensen L; Natås O; Petterson W; Skar AG; Skarpaas T; Tjade T; Asjø B
    Clin Diagn Lab Immunol; 2000 May; 7(3):451-6. PubMed ID: 10799460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the abbot Architect(™) epstein-barr virus viral capsid antigen IgM, viral capsid antigen IgG and nuclear antigen IgG assays in a pediatric and adult population.
    Grandjean Lapierre S; Vallières E; Rabaamad L; Labrecque M; Chartrand C; Renaud C
    J Clin Virol; 2016 Aug; 81():1-5. PubMed ID: 27258036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hospital based pilot study on Epstein-Barr virus in suspected infectious mononucleosis pediatric patients in India.
    Janani MK; Malathi J; Appaswamy A; Singha NR; Madhavan HN
    J Infect Dev Ctries; 2015 Oct; 9(10):1133-8. PubMed ID: 26517489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a new Epstein-Barr virus Combi Test for rapid serologic diagnosis of infectious mononucleosis.
    Dobec M; Peltier A; Levy J; Decolvenaer M; Hansen V; Beers DV; Butzler JP; Hausler WJ
    Zentralbl Bakteriol; 1996 Aug; 284(4):565-76. PubMed ID: 8899975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance of the architect EBV antibody panel for determination of Epstein-Barr virus infection stage in immunocompetent adolescents and young adults with clinical suspicion of infectious mononucleosis.
    Guerrero-Ramos A; Patel M; Kadakia K; Haque T
    Clin Vaccine Immunol; 2014 Jun; 21(6):817-23. PubMed ID: 24695777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of semi-automated EBV IgG avidity determination for the diagnosis of infectious mononucleosis.
    Weissbrich B
    J Med Virol; 1998 Feb; 54(2):145-53. PubMed ID: 9496374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic study of Epstein-Barr virus serologic assays following acute infection.
    Rea TD; Ashley RL; Russo JE; Buchwald DS
    Am J Clin Pathol; 2002 Jan; 117(1):156-61. PubMed ID: 11789721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of immunoblot-based assay for detecting Epstein-Barr virus viral capsid antibodies].
    Altuğlu I; Aksoy A; Zeytinoğlu A; Orman M
    Mikrobiyol Bul; 2010 Apr; 44(2):231-6. PubMed ID: 20549957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation the Architect EBV VCA IgM, VCA IgG, and EBNA-1 IgG chemiluminescent immunoassays to assess EBV serostatus prior transplantation.
    Maylin S; Feghoul L; Salmona M; Herda A; Mercier-Delarue S; Simon F; Legoff J
    J Med Virol; 2017 Nov; 89(11):2003-2010. PubMed ID: 28661055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the Wampole Laboratories ELISA-based assay for Epstein-Barr virus serology.
    Fung MK; Mordarski KT; Bader SA; Gronowski AM
    Clin Chim Acta; 2002 May; 319(1):43-8. PubMed ID: 11922922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of EBV-IgG anti-VCA avidity aids the early and reliable diagnosis of primary EBV infection.
    Robertson P; Beynon S; Whybin R; Brennan C; Vollmer-Conna U; Hickie I; Lloyd A
    J Med Virol; 2003 Aug; 70(4):617-23. PubMed ID: 12794726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serodiagnosis of infectious mononucleosis in children.
    Wakiguchi H; Hisakawa H; Kubota H; Kurashige T
    Acta Paediatr Jpn; 1998 Aug; 40(4):328-32. PubMed ID: 9745774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of IgG-IgM antibodies against the Epstein-Barr virus nuclear antigen (EBNA-1) using ELISA].
    Martínez Zapico R; Sobejano L; Llamazares I; Ladrón de Guevara C
    Enferm Infecc Microbiol Clin; 1992 May; 10(5):281-3. PubMed ID: 1327168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.